Sikkerheden og virkningen af administration af filgrastim hos patienter med myelodysplastisk syndrom eller kronisk myeloid leukæmi er ikke påvist.
The safety and efficacy of filgrastim administration in patients with myelodysplastic syndrome, or chronic myelogenous leukaemia have not been established.